Switching Among Biosimilars: A Review of Clinical Evidence

Keyphrases

• Anti-TNF Agents 5%
• Biological Medicines 11%
• Biological Products 5%
• Biosimilar 100%
• Chronic Inflammatory Diseases 5%
• Clinical Decision-making 5%
• Clinical Efficacy 5%
• Clinical Evidence 100%
• Clinical Practice 5%
• Clinical Safety 5%
• Cochrane Library 5%
• Disease Areas 5%
• Embase 5%
• High Cost 5%
• High Similarity 5%
• Historical Controls 5%
• Improved Patient Outcomes 5%
• MEDLINE 5%
• Multiple Switches 5%
• Problems in Practice 5%
• Quality Safety 5%
• Randomized Trial 5%
• Rational Use 5%
• Real Problems 5%
• Regulatory Requirements 5%
• Switching Study 5%

Medicine and Dentistry

• Arm 5%
• Biological Product 5%
• Biosimilar 100%
• Clinical Decision Making 5%
• Clinical Study 5%
• Cohort Analysis 11%
• Disease 5%
• Health Care Cost 5%
• Inflammatory Disorder 5%
• Medicine 11%
• Observational Study 5%
• TNF Inhibitor 5%